Inspire Medical Systems Total Current Assets 2017-2024 | INSP
Inspire Medical Systems total current assets from 2017 to 2024. Total current assets can be defined as the sum of all assets that are classified as current because they will provide a benefit within one year.
- Inspire Medical Systems total current assets for the quarter ending September 30, 2024 were $0.583B, a 2.27% increase year-over-year.
- Inspire Medical Systems total current assets for 2023 were $0.594B, a 12.02% increase from 2022.
- Inspire Medical Systems total current assets for 2022 were $0.53B, a 97.38% increase from 2021.
- Inspire Medical Systems total current assets for 2021 were $0.269B, a 0.49% decline from 2020.
| Inspire Medical Systems Annual Total Current Assets (Millions of US $) |
|
|---|---|
| 2023 | $594 |
| 2022 | $530 |
| 2021 | $269 |
| 2020 | $270 |
| 2019 | $171 |
| 2018 | $199 |
| 2017 | $24 |
| 2016 | $ |
| Inspire Medical Systems Quarterly Total Current Assets (Millions of US $) |
|
|---|---|
| 2024-09-30 | $583 |
| 2024-06-30 | $607 |
| 2024-03-31 | $572 |
| 2023-12-31 | $594 |
| 2023-09-30 | $570 |
| 2023-06-30 | $560 |
| 2023-03-31 | $534 |
| 2022-12-31 | $530 |
| 2022-09-30 | $496 |
| 2022-06-30 | $263 |
| 2022-03-31 | $262 |
| 2021-12-31 | $269 |
| 2021-09-30 | $255 |
| 2021-06-30 | $249 |
| 2021-03-31 | $261 |
| 2020-12-31 | $270 |
| 2020-09-30 | $267 |
| 2020-06-30 | $267 |
| 2020-03-31 | $155 |
| 2019-12-31 | $171 |
| 2019-09-30 | $170 |
| 2019-06-30 | $177 |
| 2019-03-31 | $189 |
| 2018-12-31 | $199 |
| 2018-09-30 | $130 |
| 2018-06-30 | $133 |
| 2018-03-31 | $27 |
| 2017-12-31 | $24 |
| 2017-09-30 | |
| 2017-06-30 | |
| 2017-03-31 | |
| 2016-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $5.892B | $0.625B |
| Inspire Medical Systems Inc. is a medical technology company. It focused on the development and commercialization of solutions for obstructive sleep apnea. The company's proprietary Inspire therapy is a neurostimulation technology which provides treatment for moderate to severe obstructive sleep apnea. Inspire Medical Systems Inc.is based in Minnesota, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tempus AI (TEM) | United States | $11.384B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $5.028B | 130.06 |
| Axonics (AXNX) | United States | $3.600B | 1760.50 |
| IRhythm Technologies (IRTC) | United States | $2.707B | 0.00 |
| Enovis (ENOV) | United States | $2.594B | 17.58 |
| Privia Health (PRVA) | United States | $2.547B | 213.00 |
| Omnicell (OMCL) | United States | $2.306B | 75.97 |
| Azenta (AZTA) | United States | $2.190B | 124.39 |
| 10x Genomics (TXG) | United States | $1.893B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.696B | 0.00 |
| Schrodinger (SDGR) | United States | $1.365B | 0.00 |
| Phreesia (PHR) | United States | $1.228B | 0.00 |
| Standard BioTools (LAB) | United States | $0.800B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.589B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.558B | 0.00 |
| Talkspace (TALK) | United States | $0.555B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.500B | 84.80 |
| Health Catalyst (HCAT) | United States | $0.498B | 0.00 |
| Pulmonx (LUNG) | United States | $0.294B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.230B | 0.00 |
| TruBridge (TBRG) | United States | $0.203B | 58.91 |
| American Well (AMWL) | United States | $0.135B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.134B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.108B | 0.00 |
| HeartBeam (BEAT) | United States | $0.068B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.065B | 0.00 |
| 111 (YI) | China | $0.059B | 0.00 |
| Zepp Health (ZEPP) | China | $0.049B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.045B | 0.00 |
| CareCloud (CCLD) | United States | $0.044B | 0.00 |
| Outset Medical (OM) | United States | $0.040B | 0.00 |
| Movano (MOVE) | United States | $0.029B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.021B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.018B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.013B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.013B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.011B | 0.00 |
| Precipio (PRPO) | United States | $0.009B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.008B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.007B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.005B | 0.00 |
| Syra Health (SYRA) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| HeartSciences (HSCS) | United States | $0.002B | 0.00 |
| Zhongchao (ZCMD) | China | $0.002B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |